Last updated on January 2020

A Phase 3, Randomized , Double Blind, Placebo controlled Study. Investigating the Efficacy and Safety of CVT-301 (Levodopa inhalation Powder) in Parkinson's Disease With Motor Response Fluctuations (Off Phenomena)

Other Details:

The study has 3 periods : A screening period, treatment period, and follow up period. there will be approximately 7 planned visits. maximum anticipated study duration will be about 19 weeks. There will be an extension trial that subjects will be able to go into after

Find a site near you

Start Over

Palm Beach Neurological Center

3365 Burns Rd. Suite 203 Palm Beach Gardens, FL USA
  Connect »